amifostine anhydrous and 16,16-dimethylprostaglandin e2

amifostine anhydrous has been researched along with 16,16-dimethylprostaglandin e2 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geng, L; Hanson, WR; Malkinson, FD1
Allalunis-Turner, MJ; Sawich, C; Walden, TL1
Hanson, WR1
Hughes, HN; Jackson, WE; Steel, LK; Walden, TL1
Albert, C; Henry, A; Maisin, JR1
Davis, HD; Kumar, KS; Landauer, MR; Weiss, JF1

Other Studies

6 other study(ies) available for amifostine anhydrous and 16,16-dimethylprostaglandin e2

ArticleYear
Topical or systemic 16, 16 dm prostaglandin E2 or WR-2721 (WR-1065) protects mice from alopecia after fractionated irradiation.
    International journal of radiation biology, 1992, Volume: 61, Issue:4

    Topics: 16,16-Dimethylprostaglandin E2; Administration, Topical; Alopecia; Amifostine; Animals; Injections, Subcutaneous; Male; Mice; Radiation Injuries, Experimental; Radiation-Protective Agents

1992
Induction of marrow hypoxia by radioprotective agents.
    Radiation research, 1989, Volume: 118, Issue:3

    Topics: 16,16-Dimethylprostaglandin E2; Amifostine; Animals; beta-Aminoethyl Isothiourea; Bone Marrow; Bone Marrow Cells; Cysteamine; Endotoxins; Female; Mice; Mice, Inbred BALB C; Oxygen; Radiation-Protective Agents; Serotonin; Superoxide Dismutase

1989
Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents.
    Radiation research, 1987, Volume: 111, Issue:2

    Topics: 16,16-Dimethylprostaglandin E2; Amifostine; Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Intestinal Mucosa; Male; Mice; Organothiophosphorus Compounds; Prostaglandins E, Synthetic; Radiation-Protective Agents; Stem Cells

1987
Protection of mice against mixed fission neutron-gamma (n: gamma = 1:1) irradiation by WR-2721, 16,16-dimethyl PGE2, and the combination of both agents.
    Radiation research, 1988, Volume: 115, Issue:3

    Topics: 16,16-Dimethylprostaglandin E2; Amifostine; Animals; Drug Therapy, Combination; Female; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neutrons; Organothiophosphorus Compounds; Prostaglandins E, Synthetic; Radiation Injuries, Experimental; Radiation-Protective Agents

1988
Reduction of short-term radiation lethality by biological response modifiers given alone or in association with other chemical protectors.
    Radiation research, 1993, Volume: 135, Issue:3

    Topics: 16,16-Dimethylprostaglandin E2; Amifostine; Animals; Cysteine; Drug Therapy, Combination; Glucans; Immunologic Factors; Male; Mice; Mice, Inbred Strains; Radiation Injuries, Experimental; Serotonin

1993
Behavioral toxicity of selected radioprotectors.
    Advances in space research : the official journal of the Committee on Space Research (COSPAR), 1992, Volume: 12, Issue:2-3

    Topics: 16,16-Dimethylprostaglandin E2; Adjuvants, Immunologic; Amifostine; Animals; Caffeine; Central Nervous System Stimulants; Cord Factors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucans; Interleukin-1; Leukotriene C4; Male; Mice; Motor Activity; Phospholipids; Platelet Activating Factor; Radiation-Protective Agents; Sulfhydryl Compounds

1992